Advocacy intelligence hub — real-time data for patient organizations
Sakarya Yenikent State Hospital — NA
Qlaris Bio, Inc. — PHASE2, PHASE3
Hospices Civils de Lyon
Peking Union Medical College Hospital
IVIEW Therapeutics Inc. — PHASE1, PHASE2
Università degli Studi 'G. d'Annunzio' Chieti e Pescara — NA
Alcon Research — PHASE3
Qlaris Bio, Inc. — PHASE2
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts — NA
Okuvision GmbH — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all NON RARE IN EUROPE: Primary adult open-angle glaucoma news →
View all NON RARE IN EUROPE: Primary adult open-angle glaucoma specialists →